1. Home
  2. KTB vs ARQT Comparison

KTB vs ARQT Comparison

Compare KTB & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kontoor Brands Inc.

KTB

Kontoor Brands Inc.

N/A

Current Price

$66.62

Market Cap

4.3B

ML Signal

N/A

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

N/A

Current Price

$23.89

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KTB
ARQT
Founded
2018
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.5B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
KTB
ARQT
Price
$66.62
$23.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
6
Target Price
$99.67
$34.00
AVG Volume (30 Days)
687.4K
1.7M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
2.94%
N/A
EPS Growth
N/A
88.79
EPS
2.82
0.03
Revenue
$2,097,839,000.00
$376,072,000.00
Revenue This Year
$10.39
$34.85
Revenue Next Year
$3.91
$29.39
P/E Ratio
$23.82
$794.67
Revenue Growth
N/A
91.34
52 Week Low
$56.19
$16.62
52 Week High
$88.96
$31.77

Technical Indicators

Market Signals
Indicator
KTB
ARQT
Relative Strength Index (RSI) 27.91 37.18
Support Level $66.20 $22.73
Resistance Level $72.18 $23.46
Average True Range (ATR) 2.78 0.79
MACD -1.15 -0.06
Stochastic Oscillator 5.67 9.76

Price Performance

Historical Comparison
KTB
ARQT

About KTB Kontoor Brands Inc.

Kontoor Brands Inc is a lifestyle apparel company. It designs, manufactures, procures, sells, and licenses apparel, footwear, and accessories, mainly under the brand names Wrangler, Lee, Helly Hansen, and a few other brands. The company also licenses the use of its brands in certain regions. Its products are sold through wholesale and direct-to-consumer channels in the United States (its key revenue-generating market) and internationally, mainly in Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Non-U.S. Americas regions. The company's three reportable segments are Wrangler, Lee, and Helly Hansen. The majority of its revenue is generated from the Wrangler segment, which offers denim, apparel, footwear, and accessories through Wrangler and various sub-brands.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: